PMDA drug package insert
ハヤナ持続性鼻炎カプセル S
PMDA OTC drug · 東和製薬株式会社 · package insert Nov 22, 2020
Key facts
| Brand names | ハヤナ持続性鼻炎カプセル S |
|---|---|
| Companies | 製造販売元／株式会社パナケイア製薬,販売会社／東和製薬株式会社 |
| Product type | OTC drug |
| OTC risk class | 第「２」類医薬品 |
| OTC dosage form | カプセル |
| OTC effect category | 鼻炎用内服薬 |
| Package insert date | Nov 22, 2020 |
| PMDA document key | 230699_K2011000024 |
| PMDA company code | 230699 |
At a glance
- 1–9 Package insert revisions
- None Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: